Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HIT HEADS 3.0: Head Injury Treatment: A Randomized, Placebo-controlled, Double-blinded, Therapeutic Clinical Trial of Branched Chain Amino Acids (BCAAs) in the Treatment of Concussion

NCT07670195 is registered in ClinicalTrials.gov with Akiva Cohen as lead sponsor.

NCT NCT07670195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07670195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HIT HEADS 3.0: Head Injury Treatment: A Randomized, Placebo-controlled, Double-blinded, Therapeutic Clinical Trial of Branched Chain Amino Acids (BCAAs) in the Treatment of Concussion
Lead sponsor
Akiva Cohen
Phase
Phase 2
Overall status
Recruiting
Start date
August 5, 2026
Completion date
December 31, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

concussion, concussion (diagnosis), concussion, brain, mtbi - mild traumatic brain injury